Cardiovascular manifestations of HIV infection

Circulation

Volumn 106, Issue 11, 2002, Pages 1420-1425

  Barbaro, Giuseppe ^a  

^a NONE   (Italy)

Author keywords

AIDS; Atherosclerosis; Cardiomyopathy; Hypertension, pulmonary; Myocarditis

Indexed keywords

ABACAVIR; ALPHA INTERFERON; AMPHOTERICIN B; AMPRENAVIR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLARITHROMYCIN; COTRIMOXAZOLE; DELAVIRDINE; DIGOXIN; DIPYRIDAMOLE; DOXORUBICIN; EFAVIRENZ; ERYTHROMYCIN; FOSCARNET SODIUM; GANCICLOVIR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INDINAVIR; NELFINAVIR; NEVIRAPINE; PENTAMIDINE; PREDNISONE; RIFAMPICIN; RITONAVIR; SAQUINAVIR; SILDENAFIL; UNINDEXED DRUG; WARFARIN; ZIDOVUDINE;

ATHEROSCLEROSIS; AUTOIMMUNITY; BLOOD CLOTTING DISORDER; BRAIN DISEASE; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENDOCARDITIS; HEART ARRHYTHMIA; HEART DILATATION; HEART DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; KAPOSI SARCOMA; LACTIC ACIDOSIS; LYMPHOMA; MYOCARDITIS; NUTRITIONAL DEFICIENCY; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; VASCULITIS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BLOOD COAGULATION DISORDERS; CARDIOMYOPATHY, DILATED; CARDIOVASCULAR DISEASES; CORONARY ARTERIOSCLEROSIS; ENDOCARDITIS; HIV INFECTIONS; HUMANS; HYPERTENSION; HYPERTENSION, PULMONARY; NEOPLASMS; PERICARDIAL EFFUSION; VASCULITIS;

EID: 0037056082     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000031704.78200.59     Document Type: Review

References (35)

1. Pathogenesis of HIV-associated cardiovascular complications
2. Overview of HIV infection
3. HIV infection and the cardiovascular system
4. The intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy
5. 2 HIV multicenter study
6. Cardiac involvement in the acquired immunodeficiency syndrome: A multicenter clinicalpathological study
7. Cardiac autoimmunity in HIV related heart muscle disease
8. Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection
9. Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of TNF-α and iNOS
10. Malnutrition and cardiac abnormalities in the HIV-infected patients
11. Cardiac dysfunction in the HIV-1 transgenic mouse treated with zidovudine
12. Absence of cardiac toxicity of zidovudine in infants
13. Immunoglobulins and left ventricular structure and function in pediatrics HIV infection
14. Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement
15. Pericardial effusion in AIDS: Incidence and survival
16. Infective endocarditis in intravenous drug users: A comparison of human immunodeficiency virus type 1-negative and -positive patients
17. Cardiac surgery in patients infected with human immunodeficiency virus
18. Role of human immunodeficiency virus in primary pulmonary hypertension: Case reports
19. Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension
20. Kawasaki-like syndromes associated with human immunodeficiency virus infection
21. Takayasu's arteritis in a human immunodeficiency virus-infected adolescent
22. HIV-associated coronary arteritis in a patient with fatal myocardial infarction
23. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
24. Antiretroviral therapy-associated hyperlipidemia in HIV disease
25. An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients
26. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction
27. Severe coronary heart disease with protease inhibitors
28. Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: The Frankfurt HIV-cohort study
29. Hypertension in the HIV-infected patient
30. Elevated blood pressure in subjects with lipodystrophy
31. Acute brachial artery thrombosis as the initial manifestation of human immunodeficiency virus infection
32. Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance
33. Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group
34. Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile
35. Epidemiology of HIV-associated malignancies